This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy International
September 16-18, 2025
Hynes Convention CenterBoston, MA
Register for Passes Today
Menu
Book Now
Key Sessions
Kristy Wood
Leveraging Gene Editing Technologies for Precision and Efficiency in Cell and Gene Therapy Development
Intellia Therapeutics
Ying Cai
Keynote Panel Discussion: Strategies for Scaling Up, Accelerating and Commercializing Gene Therapy Manufacturing
Ultragenyx Pharmaceutical
keyboard_arrow_right

Wednesday, September 17th, 2025 - Main Conference Day One - ET (Eastern Time, GMT-05:00)

keyboard_arrow_leftSearch & Filter
search
Wednesday, September 17th, 2025 - Main Conference Day One - ET (Eastern Time, GMT-05:00)
search
Showing 1 of 1 Streams
8:50am - 9:00am
Chairperson’s Opening Remarks: Gene Therapy Manufacturing & Analytics
  • Francesca Vitelli, PhD - VP Global head of Process and Analytical Development and Innovation (PADI), Minaris
9:00am - 10:00am
Keynote Panel Discussion: Strategies for Scaling Up, Accelerating and Commercializing Gene Therapy Manufacturing
  • Ying Cai - MSAT Executive Director, Ultragenyx Pharmaceutical
  • Nripen Singh - Head of Process Development, TRD CGT, Novartis
  • Vaishali Shukla - Vice President, CGT & API Global Expansion, Eli Lilly and Company
  • James Warren - Senior VP, Global CMC Development, Ultragenyx Pharmaceutical Inc.
10:00am - 10:30am
Tech Transfer Best Practices in Gene Therapy
  • Jordan Ball - Sr. Manager, Technology Transfer, Regeneron
Showing 1 of 1 Streams
11:30am - 12:00pm
Expanding the Upstream Toolbox: Enabling High-Productivity, Robust, and Scalable AAV Production
  • Huize Yan - Senior Scientist, Cell Culture Development, Genentech
12:00pm - 12:30pm
Rapid Development of AAV Purification Process Without Sacrificing Recovery
  • Hunter Reese - Scientist II, AskBio
12:30pm - 1:00pm
Accelerated Downstream Development of Viral Vectors Using High-Throughput Process, Analytical, and Formulation Technologies
  • Kevin Vera - Scientist II, Process Development, Pharma Services Group, Thermo Fisher Scientific
  • Junyan Zhang - Sr Manager, Downstream Process Development, Pharma Services Group, Thermo Fisher Scientific
Showing 1 of 1 Streams
2:10pm - 2:15pm
Chairperson’s Opening Remarks: Gene Therapy Manufacturing & Analytics
  • David Dobnik - Research Councillor, National Institute of Biology
2:15pm - 2:45pm
Bioprocessing Innovation: Developing Forward-Looking Strategy with Fiber Chromatographic Clarification Platform from Discovery to Manufacturing
  • Eric Vélez Justiniano - Senior Bioprocess Applications Engineer, Solventum
2:45pm - 3:15pm
Application of Novel Technologies to Deliver AAV Downstream Processes with Higher Yield and Better Quality
  • Junfen Ma - Head of Genomic Medicine Purification Process Development, Sanofi
3:15pm - 3:45pm
Optimizing AAV and LV Purification and Analytics: Accelerated High-Quality Processes using CIM® Monoliths and PATfix®
  • Hana Jug - Product Manager (Enveloped viruses, VLPs and EVs), Sartorius BIA Separations
Showing 1 of 1 Streams
4:30pm - 5:00pm
Detectability and Propagation of MVM in HEK293 Cells: What it means for your Viral Safety Strategy
  • Dana Schreffler - Sr. Manager QC Viral Safety, Regeneron
5:00pm - 5:30pm
Mastering hcDNA: A Harmonized CMC Approach in AAV Therapies
  • Parag Kumthekar - Gene Therapy Downstream Process Development Lead, UCB Pharma
Tuesday 16th September, 2025 - Workshop & Keynotes
NextThursday 18th September, 2025 - Main Conference Day Two
Filter
Streams
Clear
Choose Day